# Immunoglobulin, Diagnosis, Evaluation, and Key Learnings Patient Registry (IDEaL™)

> **NCT01109810** · — · COMPLETED · sponsor: **Coram Clinical Trials** · enrollment: 496 (actual)

## Conditions studied

- IVIg or SCIg Therapy in the Home or at Alternate Site

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01109810
- **Lead sponsor:** Coram Clinical Trials
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-08
- **Primary completion:** 2022-06-10
- **Final completion:** 2022-06-10
- **Target enrollment:** 496 (ACTUAL)
- **Last updated:** 2022-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109810, "Immunoglobulin, Diagnosis, Evaluation, and Key Learnings Patient Registry (IDEaL™)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01109810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*